A single graph can reveal a lot about how Tenacibaculum maritimum infection progresses in Atlantic salmon—and why timing matters when evaluating potential solutions.

This experimental challenge shows mortality remaining relatively low early on before accelerating dramatically later in the study, reaching approximately 78% cumulative mortality by Day 32.

But the real question isn’t simply how many fish survive. It’s whether an intervention can change the curve.

Explore what this mortality curve tells us about disease progression, challenge models and evaluating vaccines, functional feeds and other strategies against T. maritimum.